MedPath

Ovariopexy for Adhesion Prevention After Laparoscopic Removal of Endometriosis of the Pelvic Side Wall or the Ovary

Not Applicable
Completed
Conditions
Adhesion
Endometriosis
Surgery
Interventions
Procedure: placebo operation
Procedure: ovariopexy
Registration Number
NCT04669756
Lead Sponsor
University Hospital Muenster
Brief Summary

prospective randomized Trial comparing ovariopexy over 2, 4 or 6 days vs Placebo after surgery because of endometriosis of the pelvic side wall or the ovary or both

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
409
Inclusion Criteria
  • premenopausal
  • wants to participate
  • removal of endometriosis of the pelvic side wall or ovary
Exclusion Criteria
  • postmenopausal
  • cannot give informed consent
  • no endometriosis during Operation
  • no Opening of pelvic side wall or ovary during the Operation
  • pregnant
  • breast feeding

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Dplacebo operationPlacebo Operation for 2 days
Aovariopexyovariopexy for 2 days
Bovariopexyovariopexy for 4 days
Covariopexyovariopexy for 6 days
Primary Outcome Measures
NameTimeMethod
prevalence of postoperative ovarian adhesions3 months after operation

prevalence of postoperative ovarian adhesions

Secondary Outcome Measures
NameTimeMethod
postoperative infectious complicationsup to 3 months after operation

postoperative infectious complications

postoperative paindaily during postoperative hospitalisation and at follow up visit after 3 months

postoperative pain (NRS)

AMHat follow up visit after 3 months

AMH level

Trial Locations

Locations (1)

University Hospital Muenster

🇩🇪

Münster, NRW, Germany

© Copyright 2025. All Rights Reserved by MedPath